These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 446188)

  • 21. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
    Wallace RJ; Wiss K; Bushby MB; Hollowell DC
    Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro antibacterial activity of the trimethoprim/sulfadiazine combination].
    Russo G; Geraci C; Stefani S; Toscano MA; Mezzatesta M; Nicoletti G
    G Ital Chemioter; 1985; 32(1):211-5. PubMed ID: 3830781
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the antibacterial activity of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Legler F
    Arzneimittelforschung; 1976; 26(42):658-61. PubMed ID: 947327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitivity of bacterial strains to Biseptol. I. Effect of Biseptol, sulfamethoxazole and trimethoprim against Gram-negative bacteria].
    Piatkowski K; Horoszewicz-Malafiej A; Malafiej E
    Med Dosw Mikrobiol; 1974; 26(4):281-9. PubMed ID: 4444372
    [No Abstract]   [Full Text] [Related]  

  • 25. [The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them].
    Busk HE; Korner B; Hammer R
    Ugeskr Laeger; 1985 Nov; 147(48):3895-7. PubMed ID: 3878615
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteriological study on the chemotherapeutic combination sulfametrole-trimethoprim/comparison with co-trimoxazole (author's transl)].
    Nabert-Bock G; Grims H
    Arzneimittelforschung; 1977; 27(6):1109-17. PubMed ID: 578421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.
    Spicehandler J; Pollock AA; Simberkoff MS; Rahal JJ
    Rev Infect Dis; 1982; 4(2):562-5. PubMed ID: 6981172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility testing to trimethoprim alone and combined with sulphonamides.
    Dornbusch K; Gezelius L
    Chemotherapy; 1980; 26(6):418-26. PubMed ID: 7408555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia.
    Wallace RJ; Septimus EJ; Williams TW; Conklin RH; Satterwhite TK; Bushby MB; Hollowell DC
    Rev Infect Dis; 1982; 4(2):315-25. PubMed ID: 6981158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy of trimethoprim-sulfamethoxazole.
    Bushby SR
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):63-6. PubMed ID: 1093654
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides.
    O'Brien TF; Acar JF; Altmann G; Blackburn BO; Chao L; Courtieu AL; Evans DA; Guzman M; Holmes M; Jacobs MR; Kent RL; Norton RA; Koornhof HJ; Medeiros AA; Pasculle AW; Surgalla MJ; Williams JD
    Rev Infect Dis; 1982; 4(2):351-7. PubMed ID: 7111960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetic study of four different sulfonamides in combination with trimethoprim in human volunteers.
    Garg SK; Ghosh SS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):23-5. PubMed ID: 3485584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility, growth kinetic and pathogenicity of thymidine-requiring Streptococcus species.
    Fu KP; Kimble EF; Coldreck RJ; Konopka EA
    Chemotherapy; 1984; 30(6):373-8. PubMed ID: 6335073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
    Yogev R; Moxon ER
    J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of anaerobes to co-trimoxazole.
    Wüst J
    Infection; 1980; 8 Suppl 2():S187-9. PubMed ID: 7450860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole.
    Grey D; Hamilton-Miller JM
    J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.